Mohs micrographic surgery for melanoma: A case series, a comparative study of immunostains, an informative case report, and a unique mapping technique

Dermatologic Surgery

Volumn 28, Issue 8, 2002, Pages 656-665

  Albertini, John G ^a,b   Elston, Dirk M ^a   Libow, Lester F ^a   Smith, Sidney B ^a   Farley, Mary F ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Skin Surgery Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURGERY; CASE REPORT; CASE STUDY; CHEMOSURGERY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; FEMALE; FROZEN SECTIONS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; MOHS SURGERY; NEOPLASM INVASIVENESS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0036677967     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.02024.x     Document Type: Article

References (85)

1. Diagnosis and treatment of early melanoma
2. Guidelines of care for malignant melanoma
3. Current therapy for cutaneous melanoma
4. Treatment of lentigo maligna and lentigo maligna melanoma
5. Treatment of lentigo maligna and lentigo maligna melanoma
6. Surgical margins for excision of primary cutaneous melanoma
7. Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma
8. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma
9. Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial
10. Stage 1 melanoma of the skin: The problem with resection margins. WHO Collaborating Center for evaluation of methods of diagnosis and treatment of melanoma
11. Narrowing resection margins for patients with low-risk melanoma
12. A comparison of local recurrence and resection margins for stage 1 primary cutaneous malignant melanomas
13. Safe margin in the excision of primary cutaneous melanoma
14. Prognostic factors in thin cutaneous malignant melanoma
15. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma
16. Narrower margins for clinical stage 1 malignant melanoma
17. Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanomas
18. Thin stage 1 primary cutaneous malignant melanoma: Comparison of excision with margins of 1 or 3 cm
19. Efficacy of 2 cm surgical margins for intermediate thickness melanomas (1-4 mm): Results of a multi-institutional randomized surgical trial
20. The effects of surgical treatment on survival and local recurrences of cutaneous malignant melanoma
21. Unreliability of frozen sections in the histologic evaluation of malignant melanoma
22. Lentigo maligna and Mohs
23. A dermatopathologist looks at Mohs micrographic surgery
24. Mohs surgery and malignant melanoma
25. Patterns of local horizontal spread of melanomas
26. Chemosurgery for melanoma
27. Microscopically controlled surgery for periorbital melanoma: Fixed-tissue and fresh-tissue techniques
28. Fixed-tissue micrographic surgery for melanoma of the ear
29. Mohs micrographic surgery fixed-tissue technique for melanoma of the nose
30. Cutaneous malignant melanoma treated by Mohs surgery: Review of the treatment results of 179 cases from the Mohs melanoma registry
31. Lentigo maligna: The use of rush permanent sections in therapy
32. Mohs micrographic surgery for melanoma
33. Mohs micrographic surgery for the treatment of primary cutaneous melanoma
34. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: A follow-up study
35. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs micrographic surgery aided by rush permanent sections
36. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control
37. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: Utility of immunoperoxidase staining and supplemental vertical sections
38. Margin control for lentigo maligna
39. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: The "square" procedure
40. Mohs micrographic excision of melanoma using immunostains
41. The reliability of frozen sections in the evaluation of surgical margins for melanoma
42. Frozen section examination in the diagnosis of cutaneous malignant melanoma (melanoblastoma)
43. Diagnosis by frozen section examination. II: Results in skin lesions
44. Frozen section diagnosis of suspected malignant melanomas of the skin
45. Cutaneous melanoma: The Queensland experience
46. Pitfalls in frozen section diagnosis of malignant melanoma
47. Accuracy of and reasons for frozen sections: A correlative, retrospective study
48. Surgical treatment of lentigo maligna and lentigo maligna melanoma
49. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma
50. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma
51. Studies of the melanocytes of the epidermis adjacent to tumors
52. A study of melanocytes in the normal skin surrounding malignant melanomata
53. The width and depth of the spread of malignant melanomas as observed by a chemosurgeon
54. Mohs surgery for lentigo maligna
55. Sequential histologic study of evolving lentigo maligna melanoma
56. Surgery of extensive, subclinical lentigo maligna
57. Amelanotic malignant melanoma
58. Effusion cytology of malignant melanoma: A morphologic and immunocytochemical analysis including application of the MART-1 antibody
59. Comparison of immunohistochemical staining of the novel antibody Melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants
60. Tyrosinase, Melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections
61. Melan A (MART-1): A new monoclonal antibody for malignant melanoma diagnosis
62. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
63. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T-cells infiltrating into tumor
64. Melan-A, a new melanocytic differentiation marker
65. A103, an anti Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues
66. Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
67. Melan-A/MART-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumors
68. Immune selection after antigen-specific immunotherapy of melanoma
69. Melanoma-associated antigen recognized by T cells (MART-1). The advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration
70. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp 100 in metastatic melanoma lesions: Implications for immunotherapy
71. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo
72. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma
73. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
74. Differential expression of MART-1 in primary and metastatic melanoma lesions
75. Melanoma-associated antigens as messenger RNA detection markers for melanoma
76. Analysis of expression of the melanoma-associated antigens MART-1 and gp 100 in metastatic melanoma cell lines and in in situ lesions
77. Infrequent expression of the MAGE gene family in uveal melanomas
78. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin: Assessment of the significance of histopathologic criteria for differential diagnosis
79. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma. Higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45
80. Lentigo maligna is more common on the driver's side
81. Effects of aging and chronic sun exposure on melanocytes in human skin
82. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin
83. Melanocytic hyperplasia in scars: A histopathological investigation of 722 cases
84. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy
85. Chromosomal gains and loses in primary cutaneous melanomas detected by comparative genomic hybridization